Status:
WITHDRAWN
VEGF In Systemic Circulation Of ROP-infants
Lead Sponsor:
University Hospital Freiburg
Conditions:
Retinopathy of Prematurity (ROP)
Eligibility:
All Genders
Brief Summary
The purpose of this study is to measure systemic levels of vascular endothelial growth factor (VEGF) and other proteins (e.g. IGF-1) in the systemic circulation of infants with retinopathy of prematur...
Eligibility Criteria
Inclusion
- Clinical diagnosis of retinopathy of prematurity requiring treatment
Exclusion
- Anemia
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01470430
Start Date
March 1 2012
Last Update
January 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Eye Hospital
Freiburg im Breisgau, Baden-Wurttemberg, Germany, 79106